Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions
Authors:
- 1 November 2015
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 116 (9) , 1321-1328
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2015 UpdateCirculation, 2015
- Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical TrialCirculation: Cardiovascular Quality and Outcomes, 2014
- Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1cAmerican Heart Journal, 2014
- Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina PectorisAmerican Journal of Cardiovascular Drugs, 2013
- Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable AnginaJACC, 2013
- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart DiseaseJACC, 2012
- Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of AnginaClinical Therapeutics, 2012
- Economic Impact of Angina After an Acute Coronary SyndromeCirculation: Cardiovascular Quality and Outcomes, 2009
- Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled TrialCirculation, 2009
- Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetesEuropean Heart Journal, 2005